Orthobiologics Market Trends

Growth Drivers

Growing Number of Bone Fractures to Boost the Market Growth
For instance, the estimated number of bone fractures received is approximately 1000 fractures per 100,000 people every year.
Increasing Sales of Orthopedic Devices
As of 2022, the orthopedic devices segment was valued at around USD 40 billion.
A wide array of technologies is included in orthobiologics to improve the functionality of the broken bone. Components such as, scaffolds to reinforce tissue, cell therapies, and bone grafting materials are used in the therapy. Orthobiologics is associated with bone injuries, for instance, osteoporosis, osteonecrosis, bone infection, and density.
Higher Prevalence of Orthopedic Injuries
The prevalence of orthopedic injuries can be observed by the fact that more than 6 million orthopedic surgeries are performed every year solely in the USA.
Rising Cases of Osteoporosis Across the Globe
It is observed that 1 in 2 women and 1 in 5 men aged 50 or over suffer from osteoporosis globally. Furthermore, in 2017-18, more than 18% of women were predicted to be living with osteoporosis.
Significant growth in the Healthcare Expenditure
World Bank published statistics showing that in 2019, the healthcare expenditure reached 1,121.9 U.S. dollars per Capita.

Challenges

Higher Cost Associated with the Treatment
Lack of Skilled Medical Professionals and Requisite Technology
Presence of the Alternatives in the Market

Orthobiologics Market: Key Insights

Base Year	2024
Forecast Year	2025-2037
CAGR	5.7%
Base Year Market Size (2024)	USD 8.46 billion
Forecast Year Market Size (2037)	USD 17.04 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of orthobiologics is evaluated at USD 8.84 billion.

The orthobiologics market size was valued at USD 8.46 billion in 2024 and is expected to exceed USD 17.04 billion by the end of 2037, expanding at over 5.7% CAGR during the forecast period i.e., between 2025-2037. Increasing sales of orthopedic devices and rising cases of osteoporosis across the globe will boost the market growth.

North America industry is poised to hold largest revenue share by 2037, due to rising geriatric population with severe bone diseases and ongoing development in the healthcare expenditure of the region.

The major players in the market include Wright Medical Group N.V., Zimmer Biomet Holdings, Inc., Arthrex, Inc., Medical Device Business Services, Inc., Johnson & Johnson & Services, Inc., RTI Surgical, Inc., MTG Learning Media Pvt. Ltd., and others.

Orthobiologics Market Trends